First published: Wed Jan 13 2021(Updated: )
A vulnerability in the web-based management interface of Cisco DNA Center software could allow an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack against a user of the interface of an affected device. The vulnerability exists because the web-based management interface does not properly validate user-supplied input. An attacker could exploit this vulnerability by persuading a user to click a crafted link. A successful exploit could allow the attacker to execute arbitrary script code in the context of the interface or access sensitive, browser-based information. To exploit this vulnerability, an attacker would need to have administrative credentials on the affected device.
Credit: ykramarz@cisco.com
Affected Software | Affected Version | How to fix |
---|---|---|
Cisco DNA Center | <2.2.1.0 |
Sign up to SecAlerts for real-time vulnerability data matched to your software, aggregated from hundreds of sources.
CVE-2021-1130 is a vulnerability in the web-based management interface of Cisco DNA Center software that allows an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack.
CVE-2021-1130 has a severity rating of medium, with a CVSS score of 4.8.
CVE-2021-1130 affects Cisco DNA Center software versions up to and including 2.2.1.0.
An authenticated, remote attacker can exploit CVE-2021-1130 to conduct a cross-site scripting (XSS) attack against a user of the Cisco DNA Center web-based management interface.
Yes, Cisco has released a security advisory providing details on how to mitigate the vulnerability. Please refer to the provided reference link for more information.